CD4 and myeloid sarcoma: In this way, damage to myelin, as observed in MS, together with activation of CD4+CD20+ T cells promoting MHCII-expression on endothelial cells, could enhance the CNS antigen-specific T cell response and progression of the nervous tissue damage.